Shen’ge Formula Protects Cardiac Function in Rats with Pressure Overload-Induced Heart Failure

References

• Virani A SS, Alonso EJ, Benjamin MS, et al. Stroke statistics, heart disease and stroke statistics-2020 update: a report from the American Heart association. Circulation. 2020;141:e139–e596. doi:10.1161/CIR.0000000000000757
   PubMed Web of Science ®Google Scholar
• Maggioni AP, Dahlstrom U, Filippatos G, et al. Heart failure association of the European Society of, EURObservational research programme: regional differences and 1-year follow-up results of the heart failure pilot survey (ESC-HF Pilot). Europ J Heart Fail. 2013;15:808–817. doi:10.1093/eurjhf/hft050
   PubMed Web of Science ®Google Scholar
• Hao G, Wang X, Chen Z, et al. China Hypertension Survey, Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012-2015. Europ J Heart Fail. 2019;21:1329–1337. doi:10.1002/ejhf.1629
   PubMed Web of Science ®Google Scholar
• Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245–262. doi:10.1016/j.yjmcc.2016.06.001
   PubMed Web of Science ®Google Scholar
• Fan J, Li H, Nie X, et al. MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis. Aging. 2018;10:2459–2479. doi:10.18632/aging.101562
   PubMedGoogle Scholar
• Chen S, Zhang Y, Lighthouse JK, et al. A novel role of cyclic nucleotide phosphodiesterase 10a in pathological cardiac remodeling and dysfunction. Circulation. 2020;141:217–233. doi:10.1161/CIRCULATIONAHA.119.042178
   PubMed Web of Science ®Google Scholar
• He X, Zeng H, Chen JX. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease. J Cell Physiol. 2019;234:2252–2265. doi:10.1002/jcp.27200
   PubMed Web of Science ®Google Scholar
• Hojo Y, Saito T, Kondo H. Role of apoptosis in left ventricular remodeling after acute myocardial infarction. J Cardiol. 2012;60:91–92. doi:10.1016/j.jjcc.2012.05.014
   PubMed Web of Science ®Google Scholar
• Sano M, Komuro I. p53と心不全発症 [P53 and its role in the development of heart failure]. Japan J Clin Med. 2008;66:1013–1021. Japanese.
   PubMedGoogle Scholar
• Feng X, Liu X, Zhang W, Xiao W. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J. 2011;30:3397–3415. doi:10.1038/emboj.2011.248
   PubMed Web of Science ®Google Scholar
• Gogiraju R, Xu X, Bochenek ML, et al. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. J Americ Heart Assoc. 2015;4. doi:10.1161/JAHA.115.001770
   PubMed Web of Science ®Google Scholar
• Katare PB, Nizami HL, Paramesha B, Dinda AK, Banerjee SK. Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation. Sci Rep. 2020;10:19232. doi:10.1038/s41598-020-75301-4
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang Y, Zhou D, Zhou S, Chen W. Clinical observation of ”Ginseng-Gecko Powder” in treating congestive heart failure. Shanghai J Traditional Chin Med. 2010;44:59–61. doi:10.16305/j.1007-1334.2010.06.032
   Google Scholar
• Yang J, Cao M, Yuan S. Treatment of chronic heart failure with Shenge Powder based on cardiopulmonary syndrome. Tianjin J Traditional Chin Med. 2019;36:27–30. doi:10.11656/j.issn.1672-1519.2019.01.08
   Google Scholar
• Qiao S, Li G, Ding L, et al. Clinical observation on the adjunctive therapy with shenge powder treating 36 cases of chronic heart failure of heart and kidney yang deficiency syndrome. J Traditional Chin Med. 2020;61:1536–1540. doi:10.13288/j.11-2166/r.2020.17.015
   Google Scholar
• Cui B, Zheng Y, Zhou X, et al. Repair of adult mammalian heart after damages by oral intake of Gu Ben Pei Yuan San. Front Physiol. 2019;10:607. doi:10.3389/fphys.2019.00607
   PubMed Web of Science ®Google Scholar
• Chang H, Li C, Wang Q, et al. QSKL protects against myocardial apoptosis on heart failure via PI3K/Akt-p53 signaling pathway. Sci Rep. 2017;7:16986. doi:10.1038/s41598-017-17163-x
   PubMed Web of Science ®Google Scholar
• Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovascul Res. 1988;22:686–695. doi:10.1093/cvr/22.10.686
   PubMed Web of Science ®Google Scholar
• Liu Q, Qu HY, Zhou H, et al. Luhong formula has a cardioprotective effect on left ventricular remodeling in pressure-overloaded rats, evidence-based complementary and alternative medicine. eCAM. 2020;2020:4095967. doi:10.1155/2020/4095967
   Google Scholar
• Xu S, Bian R, Chen X. Experimental Methodology of Pharmacology. Beijing: People’s Health Publishing House; 2002.
   Google Scholar
• Qiu B, Wei Y, Yuan S, et al. Protective effect of shen’ge powder on heart failure induced by pressure overload in rats and underlying mechanism. Chin Archiv Tradit Chin Med. 2022;40:54–57. doi:10.13193/j.issn.1673-7717.2022.04.010
   Google Scholar
• Watanabe K, Ohta Y, Inoue M, et al. Bisoprolol improves survival in rats with heart failure. J Cardiovascul Pharmacol. 2001;38(1):S55–8. doi:10.1097/00005344-200110001-00012
   PubMedGoogle Scholar
• Ni Y, Wang T, Zhuo X, et al. Bisoprolol reversed small conductance calcium-activated potassium channel (SK) remodeling in a volume-overload rat model. Mol Cell Biochem. 2013;384:95–103. doi:10.1007/s11010-013-1785-5
   PubMed Web of Science ®Google Scholar
• Huang C, Zhou S, Chen C, et al. Biodegradable redox-responsive aiegen-based-covalent organic framework nanocarriers for long-term treatment of myocardial ischemia/reperfusion injury. Small. 2022;18:e2205062. doi:10.1002/smll.202205062
   PubMed Web of Science ®Google Scholar
• Meng Q, Guo Y, Zhang D, Zhang Q, Li Y, Bian H. Tongsaimai reverses the hypertension and left ventricular remolding caused by abdominal aortic constriction in rats. J Ethnopharmacol. 2020;246:112154. doi:10.1016/j.jep.2019.112154
   PubMed Web of Science ®Google Scholar
• Mei Z, Wang X, Liu W, et al. Mitochondrial adaptations during myocardial hypertrophy induced by abdominal aortic constriction. Cardiovas Pathol. 2014;23:283–288. doi:10.1016/j.carpath.2014.05.003
   PubMed Web of Science ®Google Scholar
• Li YL, Ju JQ, Yang CH, Jiang HQ, Xu JW, Zhang SJ. Oral Chinese herbal medicine for improvement of quality of life in patients with chronic heart failure: a systematic review and meta-analysis. Quality Life Res. 2014;23:1177–1192. doi:10.1007/s11136-013-0582-7
   PubMed Web of Science ®Google Scholar
• Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Amer Coll Cardiol. 2017;69:2952–2966. doi:10.1016/j.jacc.2017.04.041
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337–344. doi:10.1001/jama.287.3.337
   PubMed Web of Science ®Google Scholar
• Pharand C, Ackman ML, Jackevicius CA, et al. Canadian cardiovascular pharmacists, use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacoth. 2003;37:899–904. doi:10.1345/aph.1C163
   PubMedGoogle Scholar
• Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA Project. Multinational monitoring of trends and determinants of cardiovascular disease. J Internal Med. 2001;250:225–233. doi:10.1046/j.1365-2796.2001.00882.x
   Google Scholar
• Zheng X, Wang S, Zou X, et al. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Experim Anim. 2017;66:217–228. doi:10.1538/expanim.16-0121
   PubMed Web of Science ®Google Scholar
• Yang T, Miao Y, Zhang T, et al. Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model. J Pharm Pharmacol. 2018;70:830–838. doi:10.1111/jphp.12900
   PubMed Web of Science ®Google Scholar
• Wang T, Yu X, Qu S, Xu H, Han B, Sui D. Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats. Eur J Pharmacol. 2010;636:121–125. doi:10.1016/j.ejphar.2010.03.035
   PubMed Web of Science ®Google Scholar
• Eichhorn EJ, Domanski MJ, Krause-Steinrauf H, Bristow MR, Lavori PW. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. New Engl J Med. 2001;344:1659–1667. doi:10.1056/NEJM200105313442202
   PubMed Web of Science ®Google Scholar
• Lechat PF, Brunhuber KW, Hofmann R, et al. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13. doi:10.1016/S0140-6736(98)11181-9
   PubMed Web of Science ®Google Scholar
• Reiken S, Wehrens XH, Vest JA, et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation. 2003;107:2459–2466. doi:10.1161/01.CIR.0000068316.53218.49
   PubMed Web of Science ®Google Scholar
• Sari N, Katanasaka Y, Honda H, et al. Cacao bean polyphenols inhibit cardiac hypertrophy and systolic dysfunction in pressure overload-induced heart failure model mice. Planta med. 2020;86:1304–1312. doi:10.1055/a-1191-7970
   PubMed Web of Science ®Google Scholar
• De Boer RA, Pinto YM, Van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation. 2003;10:113–126. doi:10.1038/sj.mn.7800188
   PubMed Web of Science ®Google Scholar
• Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Amer Coll Cardiol. 2012;60:1455–1469. doi:10.1016/j.jacc.2011.11.082
   PubMed Web of Science ®Google Scholar
• Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circul Res. 2014;114:565–571. doi:10.1161/CIRCRESAHA.114.300507
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Ann Rev Physiol. 2014;76:39–56. doi:10.1146/annurev-physiol-021113-170322
   PubMed Web of Science ®Google Scholar
• Melincovici CS, Bosca AB, Susman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Roman J Morphol Embryol. 2018;59:455–467.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JR, Frederick JR, McCormick RC, et al. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction. J Thoracic Cardiovasc Surg. 2010;140:667–676. doi:10.1016/j.jtcvs.2009.12.037
   PubMed Web of Science ®Google Scholar
• Chang JH, Jin MM, Liu JT. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro. Biomed Pharmac. 2020;127:110188. doi:10.1016/j.biopha.2020.110188
   PubMed Web of Science ®Google Scholar
• Sun Y, Su Q, Li L, Wang X, Lu Y, Liang J. MiR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway. BMC Cardiovascul Disord. 2017;17:119. doi:10.1186/s12872-017-0549-7
   PubMed Web of Science ®Google Scholar
• Zheng N, Li H, Wang X, Zhao Z, Shan D. Oxidative stress-induced cardiomyocyte apoptosis is associated with dysregulated Akt/p53 signaling pathway. J Recept Sign Transd Res. 2020;40:599–604. doi:10.1080/10799893.2020.1772297
   PubMed Web of Science ®Google Scholar
• van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ. Myocyte apoptosis in heart failure. Cardiovascul Res. 2005;67:21–29. doi:10.1016/j.cardiores.2005.04.012
   PubMed Web of Science ®Google Scholar
• Pepe M, Mamdani M, Zentilin L, et al. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy. Circul Res. 2010;106:1893–1903. doi:10.1161/CIRCRESAHA.110.220855
   PubMed Web of Science ®Google Scholar
• Zhou CH, Zhang XP, Liu F, Wang W. Modeling the interplay between the HIF-1 and p53 pathways in hypoxia. Sci Rep. 2015;5:13834. doi:10.1038/srep13834
   PubMed Web of Science ®Google Scholar
• Wang P, Guan D, Zhang XP, Liu F, Wang W. Modeling the regulation of p53 activation by HIF-1 upon hypoxia. FEBS Lett. 2019;593:2596–2611. doi:10.1002/1873-3468.13525
   PubMed Web of Science ®Google Scholar